multi-level sharing knowledge cto course › files › congres › 2017 › mlcto2017.pdf ·...

FINAL PROGRAM

DIRECTORSAlexandre AVRAN, MDStéphane RINFRET, MD

SCIENTIFIC COORDINATORMax AMOR, MD

MULTI-LEVELCTO COURSEJUNE 29TH - 30TH

JULY 1ST 2017Nice, French Riviera

International speakers & operators

Live demonstrations from Tzanck Institute

Paramedics session

www.mlcto.comIn collaboration with

Simultaneous translation

EACCME 15075

2ND EDITION

S H A R I N G K N O W LE D G E

WELCOME LETTERDear friends,

The recanalization of coronary chronic total occlusion (CTO) has become a routine intervention to treat symptomatic patients with ischemia or heart failure. It is an evolving disci- pline, with operators constantly improving their skills in complex percutaneous coronary interventions (PCI).

More and more interventional cardiologists are eager to learn and develop CTO PCI programs in their cath labs. Learning and reviewing the basics, tips & tricks, and mastering CTO tech-niques are essential to manage patients with such complex coronary disease. We conceived this event to support their initiatives, and following the success our first Edition in 2016, we are happy to announce and welcome you to the ML CTO 2017.

The main goal of this event is to bring together passionate operators in one place, from beginners to experts, in a climate of openness and collegiality. Interventional cardiologists will find this conference to be an opportunity to strengthen their skills and learn new strategies tailored to their level.

The Multi-Level CTO Course includes didactic and practical lectures with simultaneous live cases, related to the topics covered during sessions. The first day is dedicated to CTO PCI basics in antegrade and retrograde approaches, with live case broadcasts of simpler CTO interventions. In parallel, a special session dedicated to paramedics will be held in French.The second day is focused on advanced antegrade tech-niques and basics of antegrade dissection re-entry. Finally, on the third day, the most challenging cases of the course will be performed and we will address more advanced retrograde and antegrade dissection re-entry strategies, discuss the management of complications, and share tips & tricks. A special session for fellows will also allow younger operators to present interesting clinical cases.

To allow as many operators as possible to benefit from this event, the full conference will be streamed live on:www.incathlab.com.

We truly hope this ML CTO Edition will meet all your expecta-tions, and provide a complete curriculum that is adapted to your individual expertise.

Welcome to Nice!

Alexandre Avran, MD & Stéphane Rinfret, MD

2ND EDITION


SHARING KNOWLEDGE

This meeting, translated in English and in French, is divided by level of expertise and held over 3 days.

Thursday, June 29th

LEVEL 1: DISCOVER CTO PCI - Starting a CTO program - Analysis of CTO angiographies- Guidewire selection- Prevention of complications- Choice of microcatheters- Basic antegrade CTO techniques:

basics manoevers, wire escalation, parallel wire- Starting a retrograde approach- Septal collateral channels selection and crossing- Basic retrograde CTO techniques: reverse cart,

knuckle wire, externalization and snaring

Friday, June 30th

LEVEL 2: PROGRESS IN CTO PCI- Choice of microcatheters- Complex antegrade situations:

ambiguous proximal cap, difficult proximal cap crossing with a microcatheter

- IVUS in CTOs- Management of CTO complications- Toolbox to handle perforations- Starting an antegrade dissection re-entry (ADR)- Basics for ADR devices- Mini Star Technique- Hybrid algorithm

Saturday, July 1st

LEVEL 3: MASTER CTO PCI- Solving difficult retrograde connection - IVUS in CTOs- Challenging septal connection - Ostial CTOs- Retrograde through epicardial collateral channels- Ping Pong technique- Post CABG CTOs- Complications of complex CTOs- Follow up on ML CTO 2016 cases

CONFERENCE VETTING SYSTEM SUBMISSION: COMPLIANT

LEARNING POINTS

Board & Scientific CommitteeCOURSE DIRECTORAlexandre Avran, MDSaint-Laurent-du-Var, France

COURSE DIRECTORStéphane Rinfret, MD, SMMontreal, Canada

SCIENTIFIC COORDINATORMax Amor, MDNancy, France

LIVE CASES COORDINATORLaurent Drogoul, MDSaint-Laurent-du-Var, France

PARAMEDICS COORDINATORHervé FaltotColmar, France

Local organizationTZANCK INSTITUTE DIRECTOR Michel Salvadori, MD

LIVE CASES COORDINATORS Alexandre Avran, MD

Laurent Drogoul, MD

HEAD OF CATHETERIZATION LABORATORIESPierre Meyer, MD

CATHLAB DEPARTMENT MEMBERS Philippe Durand, MD Claude Mariottini, MD

SHARING KNOWLEDGE

FACULTY

BELGIUM

• Stéphane Carlier, MD - Mons• Jo Dens, MD - Hasselt

CANADA

• Christopher Buller, MD - Toronto• Stéphane Rinfret, MD - Montreal

COREA

• Yangsoo Jang, MD - Yonsei

FINLAND

• Risto Jussila, MD - Vaasa

FRANCE

• Max Amor, MD - Nancy• Alexandre Avran, MD -

Saint-Laurent-du-Var• Nicolas Boudou, MD - Toulouse• Laurent Drogoul, MD -

Saint-Laurent-du-Var• Philippe Durand, MD - Paris• Benjamin Faurie, MD - Grenoble• Thomas Hovasse, MD - Paris• Thierry Lefèvre, MD - Paris• Sébastien Levesque, MD - Poitiers• Nicolas Lhoest, MD - Strasbourg• Pierre Meyer, MD -

Saint-Laurent-du-Var• Laurent Quilliet, MD - Tours

GERMANY

• Alexander Bufe, MD - Krefeld• Heinz Joachim Büttner, MD -

Bad Krozingen• Kambis Mashayekhi, MD -

Bad Krozingen, Germany• Nicolaus Reifart, MD - Bad Soden

GREECE

• Georges Sianos, MD - Thessaloniki

ITALY

• Lorenzo Azzalini, MD - Milano• Marouane Boukhris, MD - Catania• Mauro Carlino, MD - Milano• Andrea Gagnor, MD - Turin• Alfredo Galassi, MD - Catania• Roberto Garbo, MD - Turin

JAPAN

• Satoru Sumitsuji , MD - Suita• Masahisa Yamane, MD - Sayama

LATVIA

• Artis Kalnins, MD - Riga

POLAND

• Leszek Bryniarski, MD - Krakow• Jaroslaw Wójcik, MD - Lublin

SAUDI ARABIA

• Khalid Tammam, MD - Jeddah

SPAIN

• Javier Escaned, MD - Madrid

SWITZERLAND

• Daniel Weilenmann, MD - St. Gallen

THE NETHERLANDS

• Paul Knaapen, MD - Amsterdam

TURKEY

• Omer Goktekin, MD - Istanbul

UNITED KINGDOM

• Colm Hanratty, MD - Belfast• Jonathan Hill, MD - London• Sudhir Rathore, MD - Llandudno• Elliot Smith, MD - London• James Spratt, MD - Edinburgh

USA

• Khaldoon Alaswad, MD - Detroit• Emmanouil Brilakis, MD -

Minneapolis• Sanjog Kalra, MD - Philadelphia• William Nicholson, MD - New York• Michael R. Wyman, MD - Portland

Scientific program & Live cases presentation

The Multi-Level CTO Course is designated for a maximum of 18 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

18 European

CME credits

SHARING KNOWLEDGE

PARAMEDICS FACULTY

CANADA

• Nathalie Ferlatte - Montreal

FRANCE

• Sabrina Benmesbah - Paris• Hervé Faltot - Colmar• Aurélie Fresselinat - Bordaux

• Rafik Lamari - Amiens• Nathalie Lattarico - Grenoble• Fanny Villanova - Marne-la-Vallée• Gilles Wilhelm - Colmar

SHARING KNOWLEDGE

Thursday, June 29th Level 1: DISCOVER CTO PCI

07:00 Registrations

SESSION 1 CTO PCI BASICS Chairman: James Spratt Panelists: Emmanouil Brilakis,

Nicolaus Reifart & Michael Wyman Provoker: Alexandre Avran

08:00 Introduction Alexandre Avran & Stéphane Rinfret

08:10 Why should we treat CTOs: impact on ischemia and LV function Christopher Buller

08:30 Recent trials on CTO PCI: should it change practice? Stéphane Rinfret

08:40 Coronary angiography in planning for CTO PCI Laurent Quilliet

08:50 CTO angiographic analysis: scoring systems and algorithms Marouane Boukhris

09:00 Requirements for initiation of CTO PCI program: tools and set up Thomas Hovasse

LIVE CASE #1 Long proximal LCx CTO with ipsilateral

and controlateral visualization UNRESTRICTED SPONSORING

Operators: William Nicholson & Khalid Tammam IVUS commentator: Stéphane Carlier

09:10 Live case clinical presentation

09:20 Starting procedure

Parallel case-in-box Wake up or close: tips & tricks

for complications Risto Jussila

10:10 Vascular access

and guide selection for CTO PCI Khaldoon Alaswad

10:20 Essential basic maneuvers for CTO PCI Colm Hanratty

10:30 How to prevent common complications? Javier Escaned

10:40 Radioprotection and contrast management Nicolaus Reifart

10:50 Coffee break

SESSION 2 ANTEGRADE CTO PCI BASICS Chairman: Colm Hanratty Panelists: Khaldoon Alaswad,

Jo Dens & Javier Escaned Provoker: Christopher Buller

11:15 Antegrade strategy with sequential wire escalation James Spratt

11:30 Modern parallel wire technique Daniel Weilenmann

LIVE CASE #2 Dominant LCx CTO

with septal collateral channels UNRESTRICTED SPONSORING

Operators: Satoru Sumitsuji & Nicolas Boudou IVUS commentator: Stéphane Carlier



Parallel case-in-box Dangerous curves Lorenzo Azzalini

13:00 How and when to use dual-lumen catheters

Nicolas Lhoest

13:10 How to improve guide catheter support Benjamin Faurie

13:20 Lunch on Hyatt Terrace

SESSION 3 RETROGRADE CTO PCI BASICS Chairman: Benjamin Faurie

Panelists: Alexander Bufe, Artis Kalnins& Khalid Tammam

Provoker: Khaldoon Alaswad

14:30 Retrograde approach: step-by-step instructions William Nicholson

LIVE CASE #3 Long mid RCA CTO with a good landing zone UNRESTRICTED SPONSORING

Operators: Emmanouil Brilakis & Michael Wyman IVUS commentator: Stéphane Carlier



Parallel case-in-box Ipsilateral epicardial retrograde

CTO PCI over single radial access Gregor Leibundgut

16:00 Reverse-CART technique Masahisa Yamane

16:15 Dissection technique using knuckled wires: use and indication Elliot Smith

16:25 Externalization and snaring techniques Satoru Sumitsuji

16:40 Coffee break

Chairman: Stéphane Rinfret Panelists: Sébastien Levesque, Sudhir Rathore, Masahisa Yamane

Provoker: Benjamin Faurie

17:10 INDUSTRY SESSION

17:30 How would you approach that CTO? An interactive session

Presenters: Sébastien Levesque & Masahisa Yamane

17:50 DEBATE Tip injection should always be used

to guide septal collateral crossing Pro: Sudhir Rathore Con: Stéphane Rinfret

18:05 ML CTO career achievement interview with Heinz Joachim Büttner

18:15 Closing remarks

20:30 ML CTO Dinner at the Restaurant & Bar Lounge du Passable (15, chemin de Passable, 06230 Saint-Jean-Cap-Ferrat)

Shuttles available from the Palais de la Meditérranée (from main entrance venue) between 7:30 and 8:00pm

Dress code: History of Rock

6 European

CME credits

EXCLUSIVE ON INCATHLAB.COMDIGITAL EXTRA OF THE DAY Lecture: BVS implantation in chronically occluded vessels Antonio Serra

bit.ly/mlctoDED

SHARING KNOWLEDGE

SCIENTIFIC PROGRAM

SHARING KNOWLEDGE SHARING KNOWLEDGE

Friday, June 30th Level 2: PROGRESS IN CTO PCI

SCIENTIFIC PROGRAM

08:00 Registrations

SESSION 1 ADVANCED ANTEGRADE TECHNIQUES Chairman: Elliot Smith Panelists: Marouane Boukhris,

Omer Goktekin & Daniel Weilenmann Provoker: Christopher Buller

08:30 Microcatheter overview: how to choose and use Paul Knaapen

08:45 When you cannot cross the proximal cap with a microcatheter Jonathan Hill

LIVE CASE #4 Dominant LCx CTO

with ipsilateral collateral channels UNRESTRICTED SPONSORING

Operators: Kambis Mashayekhi & Alexander Bufe IVUS commentator: Stéphane Carlier



Parallel case-in-box Wire escalation tips & tricks

Thierry Lefèvre

10:30 Coffee break

SESSION 2 ADVANCED PROCEDURAL GUIDANCE AND COMPLICATIONS MANAGEMENT Chairman: Christopher Buller Panelists: Heinz Joachim Büttner,

Nicolas Lhoest & Khalid Tammam Provoker: Stéphane Rinfret

11:00 IVUS during CTO PCI Roberto Garbo

11:15 Principles of contrast modulation techniques Mauro Carlino

LIVE CASE #5 Ostial LAD CTO with short left main

and ipsilateral and contralateral collateral channels

UNRESTRICTED SPONSORING

Operators: Masahisa Yamane & Alexandre Avran IVUS commentator: Stéphane Carlier



Parallel case-in-box RCA ostial CTO and snaring

Andrea Gagnor 13:00 How to manage ambiguous

proximal cap without a retrograde option Alexander Bufe

13:15 How to manage CTO PCI complications Emmanouil Brilakis

13:30 Perforations: the complete toolbox and how to use it Kambis Mashayekhi


SESSION 3 BASICS IN ANTEGRADE DISSECTION RE-ENTRY Chairman: Max Amor

Panelists: Yangsoo Jang, Sanjog Kalra & Nicolaus Reifart

Provoker: Kambis Mashayekhi 14:45 Toolbox for effective dissection

re-entry techniques Jonathan Hill

LIVE CASE #6 LCx CTO with ambiguous proximal cap UNRESTRICTED SPONSORING

Operators: Roberto Garbo & Andrea Gagnor IVUS commentator: Stéphane Carlier



Parallel case-in-box Heavily calcified distal RCA CTO

uncrossable with device neither retrogradely nor anterogradely Meruzhan Saghatelyan

16:30 Coffee break

Chairman: Alexander Bufe

Panelists: Georges Sianos, Mauro Carlino & Paul Knaapen

Provoker: Thierry Lefèvre


17:15 Device-based ADR: step-by-step instructions Michael Wyman

17:30 Wire-based ADR: bailout indications and Mini-Star technique Alfredo Galassi


Presenters: Lorenzo Azzalini & Mauro Carlino

SESSION 4 CTO PCI FOR FELLOWS Chairman: Alexandre Avran

Panelists: Nicolas Boudou, Emmanouil Brilakis & Stéphane Rinfret

18:00 The hybrid algorithm: choosing the right approach Emmanouil Brilakis

18:15 Case presentations

18:45 The new Jedi meets Yoda: Q&A session All Faculty members

19:00 Closing remarks

6 European

CME credits

EXCLUSIVE ON INCATHLAB.COMDIGITAL EXTRA OF THE DAY Lecture: Management of septal complications Daniel Weilenmann

bit.ly/mlctoDED

SHARING KNOWLEDGE

Saturday, July 1st Level 3: MASTER CTO PCI

SESSION 1 RETROGRADE ADVANCED STRATEGIES Chairman: Alfredo Galassi Panelists: Philippe Durand,

Andrea Gagnor & William Nicholson Provoker: Elliot Smith

08:30 Solution for difficult retrograde re-entry Yangsoo Jang

LIVE CASE #7 Blunt mid RCA CTO UNRESTRICTED SPONSORING

Operators: Georges Sianos & Omer Goktekin IVUS commentator: Stéphane Carlier



Parallel case-in-box Late acquired malapposition

and sub-occlusive restenosis after reverse CART for ostially occluded LAD Erion Xhepa

10:15 Wire crosses septal channel but microcatheter doesn’t follow: what to do? Khalid Tammam

10:30 Retrograde approach through epicardial collateral channels Kambis Mashayekhi

10:45 Ping-pong technique for retrograde approach Nicolas Boudou

10:55 Coffee break

SESSION 2 ANTEGRADE DISSECTION RE-ENTRY ADVANCED STRATEGIES Chairman: Jonathan Hill Panelists: Kambis Mashayekhi,

Satoru Sumitsuji & Michael Wyman Provoker: Alexandre Avran


Presenters: Kambis Mashayekhi & Alexandre Avran

11:45 Difficult ADR situations: how to handle? Colm Hanratty

12:00 How to deal with ostial RCA CTOs Alexandre Avran

LIVE CASE #8 RCA CTO with good landing zone UNRESTRICTED SPONSORING

Operators: Christopher Buller & James Spratt IVUS commentator: Stéphane Carlier



Parallel case-in-box Multivessel Disease with double CTO

Eugenio La Scala


SESSION 3 DIFFICULT CTO PCI, COSTS AND OUTCOMES Chairman: Masahisa Yamane

Panelists: Max Amor, Laurent Drogoul & Risto Jussila

Provoker: Jonathan Hill 14:50 The RECHARGE registry:

what have we learned? Jo Dens

15:00 Specific issues with post-CABG CTOs Heinz Joachim Büttner

LIVE CASE #9 Long and double RCA CTO

in a post-CABG patient UNRESTRICTED SPONSORING

Operators: Stéphane Rinfret & Alexandre Avran IVUS commentator: Stéphane Carlier



Parallel case-in-box Previous CABG alter the native

coronary disease nature Albert Alahmar


16:45 Coffee break

Chairman: Omer Goktekin

Panelists: Colm Hanratty, Thomas Hovasse & Daniel Weilenmann

17:15 Supported CTO PCI using percutaneous left ventricular assist devices Sanjog Kalra

17:30 Cost of CTO PCI: the cathlab manager perspective Aurélie Fresselinat

17:40 How are they doing? Angiographic follow-up of last year cases Laurent Drogoul

18:00 Take home messages and conclusion Alexandre Avran & Stéphane Rinfret

6 European

CME credits

EXCLUSIVE ON INCATHLAB.COMDIGITAL EXTRA OF THE DAY Lecture: Overview of PERFECTO trial Sébastien Levesque

bit.ly/mlctoDED

SHARING KNOWLEDGE

SCIENTIFIC PROGRAM

LIVE CASE #3Long mid RCA CTO with a good landing zone

CLINICAL DATA • 56 yo male• Risk factors: dyslipidemia, hypertension• No history• Stable angina CCS2 – positive exercise

stress test 90 watts• TTE: LVEF 65%• Angiogram: severe disease to LAD/D1, CTO to RCA• PCI to left system (reverse TAP) 05.2017• Scintigraphy 06/2017: + posterior/

normal IVA territory

LIVE CASE #4Dominant LCx CTO with ipsilateral collateral channels

CLINICAL DATA • 71 yo male• Risk factors: hypertension, ex smoker• History: COPD• Stable angina on exertion CCS2• EF 70%• Stress perfusion: inferolateral ischemia

(Lcx territory)• Angiogram: severe disease to LAD, CTO to LCx,

mild to moderate RCA• PCI to LAD (1DES 3.5x34mm) – FFR to RCA 0.89• Lcx: AWE attempt at the end of the procedure

LIVE CASE #1Long proximal LCx CTO with ipsilateral and controlateral visualization

CLINICAL DATA • 78 yo male• Risk factors: ex-smoker, hypertension,

family history • History: AAA treated by endoprothesis,

severe PAD femoral bypass, CKF (45 MDRD)• On VKA• Admitted for stable angina• EF 45%• Ischemia 3 segments: Lcx territory• Angiogram: CTO to LCx, severe disease

to RCA, moderate PDA/PLA bifurcation, PCI to RCA - 1 DES (3.0x30 mm)

LIVE CASE #2Dominant LCx CTO with septal collateral channel

CLINICAL DATA • 74 yo female• Risk factors: dyslipidemia• Previous PCI LAD 2012• Troponin positive ACS following

carotid endarterectomy• EF 50% • Angiogram: mild to moderate ISR LAD,

significant disease to 1st OM, CTO to AV Lcx, diffuse disease to non dominant RCA

• Proceed to PCI to LCx - 1st OM with kissing ballon inflation to AV Lcx (CTO prox cap) 05.2017

• Scintigraphy 06.2017: + post and lateral

Live cases presentationSHARING KNOWLEDGESHARING KNOWLEDGE

LIVE CASE #7Blunt mid RCA CTO

CLINICAL DATA • 66 yo male• Risk factors: hypertension, current smoker• History: COPD• Exertional symptomatology (SOB/Angina) • EF 45%• Stress perfusion: positive to Lcx and RCA territory• Stress test stopped 60 Watts for symptoms

LIVE CASE #8LRCA CTO with good landing zone

CLINICAL DATA • 50 yo male• Risk factors: dyslipidemia, smoker, hypertension• History: PAD (stented)• Angina on exertion CCS2• Positive stress perfusion: severe infero

posterior segments ischemia• EF: 60%• Angiogram: severe disease to LCx - 1st OM

bifurcation, CTO to RCA• 03.2017: PCI to LCx - 1st OM: provisionnal 2DES –

final kissing• 05.2017: angina, scintigraphy + posterior

LIVE CASE #5Ostial LAD CTO with short left main and ipsilateral and contralateral collateral channels

CLINICAL DATA • 57 yo male• Risk factors: dyslipidemia – ex smoker• History: PCI to RCA 2010

(CTO to lAD medically treated) • Recent admission for chest pain at rest • Scintigraphy: + LAD territory

LIVE CASE #6LCx CTO with ambiguous proximal cap

CLINICAL DATA • 50 yo male• Risk factors: hypertension,

dyslipidemia, diabetic insulin therapy.• History: troponin positive ACS 12.2016,

PCI to OM1 • Now complains of stable angina CCS2• EF 64%, no RWMA • Angiogram: severe disease to PDA

(1DES 2,5x8), patent stent to LCX/OM, blocked LCx, atheroma to LAD

• Still symtomatic despite OMT• Stress perfusion: + LCx territory


LIVE CASE #9Long and double RCA CTO in a post-CABG patient

CLINICAL DATA • 74 yo male• Risk factors: ex smoker, dylipidemia, hypertension• History: CABG 1989 (LIMA –LAD, SVG to RCA/OM/Intermediate)• All SVG blocked 5 years ago• Stable angina CCS3 • Stress perfusion: ischemia to LCx and RCA territory • Angiogram: CTO to LAD / LCx / OM / RCA, 1st: PCI to OM (1DES) and Lcx (2DES)


AsPeCaF

Austrian Society of Cardiology

Young Cardiologists’ Club (YCC) of the Belgian Society of Cardiology

Brazilian Society of Cardiology

British Cardiovascular Intervention Society (BCIS)

Colombian Society of Cardiology and Cardiovascular Surgery

Working Group on Interventional Cardiology of the Cyprus Society of Cardiology

Danish Working Group on Interventional Cardiology

Egyptian Society of Cardiology

Working Group on Interventional Cardiology of the Finnish Cardiac Society

Atheroma Coronary and Interventional Cardiology Group of the French Society of Cardiology (GACI)

German Cardiac Society

Working Group of Hemodynamic and Interventional Cardiology of the Hellenic Cardiological Society

Young Cardiologists Group of the Irish Cardiac Society

Mexican Society of Cardiology

Latin American Society of Interventional Cardiology (SOLACI)

Latvian Society of Cardiology

Working Group on Interventional Cardiology of the Lebanese Society of Cardiology

Working Group on Interventional Cardiology of the Norwegian Society of Cardiology

Pan African Society of Cardiology (PASCAR)

Peruvian Society of Cardiology

South African Society of Cardiovascular Intervention (SASCI)

Swedish Society of Cardiology

Turkish Society of Cardiology

AFFILIATIONS

MEDIAS

EVENTS

COLLABORATION

DIAMOND

SAPPHIRE

OTHER SPONSORS

CRYSTAL

RUBY

PARTNERSSHARING KNOWLEDGE

NOTES

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

NOTES

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

NOTES

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

NOTES

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

................................................................................................................................................................................

SAVE THE DATE

DIRECTORSAlexandre AVRAN, MDStéphane RINFRET, MD

www.mlcto.com

MULTI-LEVELCTO COURSEJUNE 28TH - 29TH - 30TH 2018Nice, French Riviera

Simultaneous translation

CONTACT ORGANIZATION: Morgane Airaudi - [email protected] Tel. +33(0) 783 454 563 - www.incathlab.com

3RD EDITION


INFORMATIONVenueHyatt Regency Palais de la Méditerranée13, promenade des Anglais 06000 Nice, FranceTel. +33 0) 492 147 736Fax +33(0) 492 147 727www.nice.regency.hyatt.com

ContactGeneral organizationStanMed Morgane [email protected]. +33(0) 783 454 563www.incathlab.com

Registration & logistics

Marie [email protected]. +33(0) 491 097 053 www.comnco.com

multi-level sharing knowledge cto course › files › congres › 2017 › mlcto2017.pdf ·...

Documents